Goa-based Mol­bio Gets Test­ing Nod for Covid-19 Kit

The Economic Times - - Pure Politics - Divya.Ra­[email protected]­group.com

Mum­bai: Goa-based Mol­bio said that it has re­ceived a test­ing li­cence from the Drug Con­troller Gen­eral of India for its Covid-19 kits, a move that takes it one step closer to the launch­ing them in the In­dian mar­ket.

Mol­bio said that its point of care in­stru­ment can give out re­sults in 35 min­utes, which would make it the only In­dian firm to pro­vide quicker re­sults.

The regulator’s ap­proval means that the Na­tional In­sti­tute of In­fec­tious Stud­ies (Pune), which is the cen­tral lab for all the Covid-19 tests in the country, will val­i­date whether Mol­bio's de­vice ac­tu­ally works.

Mol­bio re­ceived over ₹100 crore fund­ing last week from pri­vate eq­uity firm Moti­lal Oswal. It is al­ready do­ing test­ing for TB de­tec­tion in India.

“Our point of care sys­tem en­sures that it is not re­stricted to only cen­tral labs. We can go to re­mote parts or even homes and get the tests done,” said Sri­ram Natara­jan, CEO of Mol­bio.

He said that there are three ver­sions of its test­ing kits. The first one can give out 12 tests, the sec­ond ver­sion 24 and third the ad­vanced can do 48 tests a day and each test re­sults will be out in 30 min­utes.

Ear­lier this week Swiss di­ag­nos­tics firm Roche also said that the com­pany had re­ceived ap­proval for its SARS-Covid-19 di­ag­nos­tic that can test thou­sands of sam­ples in 24 hours. Though Roche’s tests works on large equip­ment that is not avail­able in the country, the com­pany said it will look at ways of ad­dress­ing this. “We have the po­ten­tial to offer three types of test kits that can be used to screen and fur­ther di­ag­nose Covid-19 in­fec­tions on our ex­ist­ing sys­tems that run other in­fec­tious dis­ease pan­els,” Shra­van Subra­ma­niam, MD Roche Di­ag­nos­tics had told ET ear­lier.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.